Clinical Trials Browser

Phase 2 × Leukemia × VAP-cyclo protocol × Clear all

NCT03145480 2023-06-01

Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

Phase 2 Terminated

3 enrolled 5 charts

Other hematologic neoplasm

Leukemia

NCT00072007 2012-05-15

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell